Prescription Digital Therapeutics
PilLow RX
PilLow addresses the underlying cause of chronic insomnia by guiding patients to modify their thought processes and behavior for better sleep. PilLow's underlying mechanism, Cognitive Behavioral Therapy for Insomnia (CBT-i), is the guideline-recommended first-line therapy for insomnia.
INSOMNIA
Insomnia in Korea
Source: Health Insurance Review & Assessment Service
Source: OECD
Source: Health Insurance Review & Assessment Service
Korean Sleep Research Society
The unmet needs of insomnia
Sleep medications are only
recommended for short term use
and may have unwanted side-effects
Sleeping pills help induce
and maintain sleep, but do
not solve the underyling cause.
Limited access to first-line treatment:
Cognitive Behavioral Therapy (CBT)
Limited number of CBTi
accredited providers
What is CBT-I ?
CBT-I (I for Insomnia) coaches patients to identify feelings, thoughts and behaviors that are contributing to the symptoms of insomnia and helps reframe any misconceptions for better sleep.
Why CBT-I ?
The American College of Physicians recommends CBT-I as the first-line treatment
for all adults with chronic insomnia. Because CBT-I is noninvasive, it is likely to have fewer harms, whereas sleeping pills can be associated with serious adverse events.
It is also known to have better long term efficacy over pharmacotherapy. With more than 20 years of research, CBT-I has become the gold standard of insomnia care.
Changes in Sleep Efficiency, %
Changes in Sleep Latency, %
